Standard BioTools Inc. (FRA:FLB)

Revenue by Product

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017
Proteomics	135.79M
Proteomics Growth	112.56%
Genomics	38.64M
Genomics Growth	-8.98%

Revenue by Geography

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017
United States	89.90M
United States Growth	103.85%
Europe, Middle East and Africa	52.32M
Europe, Middle East and Africa Growth	44.52%
Asia-Pacific	16.85M
Asia-Pacific Growth	106.94%
China	11.80M
China Growth	-25.32%
Americas	3.56M
Americas Growth	69.94%